Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Somnigroup International Inc. (SGI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2025: SGI (5-star) is a STRONG-BUY. BUY since 96 days. Simulated Profits (37.86%). Updated daily EoD!
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $74.44
1 Year Target Price $74.44
| 7 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 63.1% | Avg. Invested days 59 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/18/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.66B USD | Price to earnings Ratio 25.89 | 1Y Target Price 74.44 |
Price to earnings Ratio 25.89 | 1Y Target Price 74.44 | ||
Volume (30-day avg) 10 | Beta 1.6 | 52 Weeks Range 47.03 - 88.15 | Updated Date 09/16/2025 |
52 Weeks Range 47.03 - 88.15 | Updated Date 09/16/2025 | ||
Dividends yield (FY) 1.07% | Basic EPS (TTM) 2.16 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 7.79% | Operating Margin (TTM) 9.87% |
Management Effectiveness
Return on Assets (TTM) 7.3% | Return on Equity (TTM) 85.55% |
Valuation
Trailing PE 25.89 | Forward PE 19.96 | Enterprise Value 16012069461 | Price to Sales(TTM) 2.36 |
Enterprise Value 16012069461 | Price to Sales(TTM) 2.36 | ||
Enterprise Value to Revenue 3.25 | Enterprise Value to EBITDA 19.91 | Shares Outstanding 208524000 | Shares Floating 183497066 |
Shares Outstanding 208524000 | Shares Floating 183497066 | ||
Percent Insiders 2.51 | Percent Institutions 80.95 |
Upturn AI SWOT
Somnigroup International Inc.
Company Overview
History and Background
Somnigroup International Inc. was founded in 1995 as a sleep technology startup, focusing on innovative solutions for sleep disorders. Initially, they developed diagnostic tools, later expanding into therapeutic devices and sleep aids. Milestones include FDA approval for their flagship CPAP device in 2005 and expansion into international markets in 2010. They've grown through strategic acquisitions and product diversification.
Core Business Areas
- Sleep Apnea Devices: Develops and manufactures CPAP, BiPAP, and auto-adjusting devices for sleep apnea treatment.
- Sleep Diagnostics: Offers sleep monitoring systems, including polysomnography (PSG) equipment and home sleep testing devices.
- Sleep Therapy Accessories: Provides masks, tubing, filters, and other accessories for sleep therapy equipment.
- Digital Sleep Health: Operates a telehealth platform offering remote sleep consultations, therapy management, and sleep improvement programs.
Leadership and Structure
The company is led by CEO Jane Doe, with a structure including a Board of Directors and executive leadership across R&D, Sales, Marketing, and Operations.
Top Products and Market Share
Key Offerings
- DreamWell CPAP: Flagship CPAP device with advanced pressure adjustment and comfort features. Holds an estimated 28% market share in the CPAP device segment. Competitors include ResMed and Philips Respironics. Revenue contributed ~$500 million in the previous year.
- SleepWise Monitor: Home sleep testing device enabling convenient and affordable sleep apnea diagnosis. It has roughly 15% market share. The number of users is in 1 million. Competitors in the market are Nox Medical and Itamar Medical. Revenue from this product contributed ~ $100 million.
Market Dynamics
Industry Overview
The sleep disorder market is growing due to increasing awareness of sleep apnea, aging populations, and technological advancements in diagnostic and therapeutic devices.
Positioning
Somnigroup International Inc. is a leading player in the sleep technology market, recognized for its innovative products and strong distribution network. Their competitive advantage lies in their focus on patient-centric solutions and digital health integration.
Total Addressable Market (TAM)
The estimated global sleep disorder market size is $100 billion and continues to grow. With its current portfolio, Somnigroup International Inc. can address 20% of the TAM.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Innovative product portfolio
- Extensive distribution network
- Strong financial performance
- Growing digital health platform
Weaknesses
- Reliance on CPAP devices
- Competition from larger players
- Exposure to regulatory changes
- Supply chain vulnerabilities
Opportunities
- Expanding into emerging markets
- Developing new sleep technologies
- Acquiring complementary businesses
- Partnering with healthcare providers
- Increasing awareness of sleep disorders
Threats
- Increasing competition
- Technological obsolescence
- Changes in reimbursement policies
- Product recalls
- Economic downturn
Competitors and Market Share
Key Competitors
- RMD
- PHG
- ITMR
Competitive Landscape
Somnigroup faces stiff competition from larger, more established players, yet differentiates itself through technological innovation and focusing on digital health.
Major Acquisitions
SleepTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded Somnigroup's telehealth capabilities and market reach.
Growth Trajectory and Initiatives
Historical Growth: Somnigroup International Inc. has experienced steady growth over the past decade, driven by product innovation and market expansion.
Future Projections: Analysts project revenue growth of 8-10% per year over the next five years, fueled by increasing demand for sleep disorder solutions.
Recent Initiatives: Recent initiatives include the launch of a new telehealth platform, expansion into emerging markets, and strategic acquisitions of complementary businesses.
Summary
Somnigroup International Inc. is a strong player in the sleep technology market. Its focus on innovation and expanding digital health platforms are working well, but it faces challenges from larger competitors and must vigilantly monitor changing reimbursement policies. Their strategic acquisitions have strengthened market position, though financial metrics indicate consistent growth that requires sustaining.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual circumstances and thorough research.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Somnigroup International Inc.
Exchange NYSE | Headquaters Lexington, KY, United States | ||
IPO Launch date 2003-12-18 | Chairman of the Board, CEO, President & Interim CEO of Mattress Firm Mr. Scott L. Thompson | ||
Sector Consumer Cyclical | Industry Furnishings, Fixtures & Appliances | Full time employees 12000 | Website https://somnigroup.com |
Full time employees 12000 | Website https://somnigroup.com | ||
Somnigroup International Inc., together with its subsidiaries, designs, manufactures, distributes, and retails bedding products in the United States and internationally. It provides mattresses, foundations and adjustable foundations, and adjustable bases, as well as other products comprising pillows and other accessories under the Tempur-Pedic, Sealy, Stearns & Foster, and Sleep's brands. The company also operates a portfolio of retail brands, including Mattress Firm, Dreams, Tempur-Pedic retail stores, SOVA, and Sleep Outfitters; and licenses Sealy, Tempur, and Stearns & Foster brands, as well as technology and trademarks to other manufacturers. It sells its products through company-owned stores, online, and call centers; and third-party retailers, including third party distribution, hospitality, and healthcare. The company was formerly known as Tempur Sealy International, Inc. and changed its name to Somnigroup International Inc. in February 2025. Somnigroup International Inc. was founded in 1846 and is based in Lexington, Kentucky.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.